Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label phase 1 study of binimetinib plus nivolumab in advanced or metastatic solid tumors
jRCT2080223818Phase 1Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Feb 2018
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of binimetinib and nivolumab in Nonhematologic neoplasms, sponsored by Ono Pharmaceutical. Started Feb 2018; status: completed.
02
Drugs
binimetinibnivolumab
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on jRCT2080223818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223818.